COMPASS PATHWAYS PLC -
5.3000
07-نوفمبر-24 14:59:59
15 متأخرة بدقائق
الأسهم
+0.5700
+12.05%
نطاق اليوم
4.7500 - 5.4700
ISIN
N/A
المصدر
NASDAQ
-
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
26 مايو 2023 15:00:00 بحسب Nasdaq GlobeNewswire
-
26 مايو 2023 06:00:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights
11 مايو 2023 06:00:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023
03 مايو 2023 15:01:00 بحسب Nasdaq GlobeNewswire
-
American Medical Association to Issue First New Code for Psychedelic Therapies
02 مايو 2023 06:00:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference
10 أبريل 2023 09:10:13 بحسب Nasdaq GlobeNewswire
-
02 مارس 2023 09:23:22 بحسب Nasdaq GlobeNewswire
-
24 فبراير 2023 11:01:00 بحسب Nasdaq GlobeNewswire
-
08 ديسمبر 2022 03:00:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference
28 نوفمبر 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
03 نوفمبر 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
03 نوفمبر 2022 05:00:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways plc to announce third quarter 2022 financial results on 3 November 2022
26 أكتوبر 2022 15:00:00 بحسب Nasdaq GlobeNewswire
-
12 أكتوبر 2022 10:00:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways to Hold Virtual Capital Market Day on 12 October 2022
04 أكتوبر 2022 08:05:40 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit
19 سبتمبر 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in three upcoming investor events
01 سبتمبر 2022 07:06:21 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights
04 أغسطس 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
02 أغسطس 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa
28 يوليو 2022 03:00:00 بحسب Nasdaq GlobeNewswire